BONH
TEVA icon

Bank of New Hampshire’s Teva Pharmaceuticals TEVA Stock Holding History

Bank of New Hampshire’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.55K Buy
+282
New +$9.39K ﹤0.01% 461

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.63B AUM 45.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
KHLMVGHM
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet Tel Aviv, Israel $2.44B AUM 24.95% 1-Year Est. Return
YDMI
Y.D. More Investments Ramat Gan, Israel $3.21B AUM 117.29% 1-Year Est. Return

Bank of New Hampshire's TEVA Position: Q2 2026 in Review

Bank of New Hampshire opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2026: 282 shares worth $9.55K. The stake represents ﹤0.01% of the portfolio and ranks #461 among its holdings.

342 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Bank of New Hampshire held 282 shares of Teva Pharmaceuticals worth $9.55K as of Q2 2026.
  • Teva Pharmaceuticals was a new Bank of New Hampshire position in Q2 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of Bank of New Hampshire's portfolio in Q2 2026, its #461 holding.
  • 342 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Bank of New Hampshire's 13F filing for Q2 2026, filed 14 Jul 2026.